Cargando…

Cost–benefit analysis of the polypill in the primary prevention of myocardial infarction and stroke

The primary prevention of cardiovascular disease is a public health priority. To assess the costs and benefits of a Polypill Prevention Programme using a daily 4-component polypill from age 50 in the UK, we determined the life years gained without a first myocardial infarction (MI) or stroke, togeth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wald, Nicholas J., Luteijn, Johannes Michiel, Morris, Joan K., Taylor, David, Oppenheimer, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Netherlands 2016
Materias:	Cardiovascular Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4877433/ https://www.ncbi.nlm.nih.gov/pubmed/26946426 http://dx.doi.org/10.1007/s10654-016-0122-1

Ejemplares similares

Starting the polypill: the use of a single age cut-off in males and females
por: Wald, Nicholas J, et al.
Publicado: (2016)

The polypill in the primary prevention of cardiovascular disease: cost-effectiveness in the Dutch population
por: van Gils, Paul F, et al.
Publicado: (2011)

Randomized Polypill Crossover Trial in People Aged 50 and Over
por: Wald, David S., et al.
Publicado: (2012)

Stroke survivors', caregivers' and GPs' attitudes towards a polypill for the secondary prevention of stroke: a qualitative interview study
por: Jamison, James, et al.
Publicado: (2016)

Process evaluation of the impact and acceptability of a polypill for prevention of cardiovascular disease
por: Wood, Frances, et al.
Publicado: (2015)

Practical Decision Algorithms for the Use of the Cardiovascular Polypill in Secondary Prevention in Europe
por: Grigorian-Shamagian, Lilian, et al.
Publicado: (2021)

Polypills for Primary Prevention of Cardiovascular Disease: A Systematic Review and Meta-Analysis
por: Kandil, Omneya A., et al.
Publicado: (2022)

Serum metabolites and risk of myocardial infarction and ischemic stroke: a targeted metabolomic approach in two German prospective cohorts
por: Floegel, Anna, et al.
Publicado: (2017)

Cost-Effectiveness of the CNIC-Polypill Strategy Compared With Separate Monocomponents in Secondary Prevention of Cardiovascular and Cerebrovascular Disease in Portugal: The MERCURY Study
por: Aguiar, Carlos, et al.
Publicado: (2022)

Acute myocardial infarction incidence and hospital mortality: routinely collected national data versus linkage of national registers
por: Koek, Huberdina L., et al.
Publicado: (2007)

Strengths and Limitations of Using the Polypill in Cardiovascular Prevention
por: Roy, Ambuj, et al.
Publicado: (2017)

ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION SECONDARY TO COVID-19
por: DOUEDI, STEVEN, et al.
Publicado: (2021)

WHEN ST-ELEVATION MYOCARDIAL INFARCTION (STEMI) IS JUST THE BEGINNING: DISSEMINATED INTRAVASCULAR COAGULATION (DIC) FROM COVID-19 INFECTION PRESENTING AS ACUTE MYOCARDIAL INFARCTION
por: DESHPANDE, RADHIKA, et al.
Publicado: (2022)

The relation between socioeconomic status and short-term mortality after acute myocardial infarction persists in the elderly: results from a nationwide study
por: van Oeffelen, Aloysia A. M., et al.
Publicado: (2012)

Causes and prevention of postoperative myocardial injury
por: Verbree-Willemsen, Laura, et al.
Publicado: (2018)

The Benefits of Polypill: Adherence and Chronotherapy [Response to Letter]
por: Lopez-Jaramillo, Patricio, et al.
Publicado: (2023)

Short- and long-term mortality after acute myocardial infarction: comparison of patients with and without diabetes mellitus
por: Koek, H. L., et al.
Publicado: (2007)

Incidence and 30-day case fatality for acute myocardial infarction in England in 2010: national-linked database study
por: Smolina, Kate, et al.
Publicado: (2012)

ACUTE CORONARY ARTERY THROMBOSIS AND ST-ELEVATION MYOCARDIAL INFARCTION IN AN ALREADY HOSPITALIZED PATIENT WITH COVID-19 INFECTION
por: EKIN, UTKU, et al.
Publicado: (2022)

European Primary Care Cardiovascular Society (EPCCS) consensus guidance on stroke prevention in atrial fibrillation (SPAF) in primary care
por: Hobbs, FD Richard, et al.
Publicado: (2015)

Active and passive smoking and the risk of myocardial infarction in 24,968 men and women during 11 year of follow-up: the Tromsø Study
por: Iversen, Birgitte, et al.
Publicado: (2013)

Prevention of Hypertensive Disorders of Pregnancy: a Novel Application of the Polypill Concept
por: Browne, J. L., et al.
Publicado: (2016)

Self-reported insomnia symptoms, sleep duration, chronotype and the risk of acute myocardial infarction (AMI): a prospective study in the UK Biobank and the HUNT Study
por: Arora, Nikhil, et al.
Publicado: (2023)

Cost-effectiveness and public health benefit of secondary cardiovascular disease prevention from improved adherence using a polypill in the UK
por: Becerra, Virginia, et al.
Publicado: (2015)

Rivaroxaban plus aspirin for the prevention of ischaemic events in patients with cardiovascular disease: a cost-effectiveness study
por: Petersohn, Svenja, et al.
Publicado: (2020)

Benefits of the Polypill on Medication Adherence in the Primary and Secondary Prevention of Cardiovascular Disease: A Systematic Review
por: Lopez-Lopez, Jose P, et al.
Publicado: (2023)

Polypill—Friend or Foe?
por: Rishi, Rakesh Kumar
Publicado: (2011)

Abernethy Malformation with Massively Dilated Main Pulmonary Artery Manifesting as Acute Myocardial Infarction
por: Rout, Amit, et al.
Publicado: (2021)

Would primary healthcare professionals prescribe a polypill to manage cardiovascular risk? A qualitative interview study
por: Virdee, Satnam K, et al.
Publicado: (2013)

Costs and benefits of treatment of myocardial infarction
por: Simoons, M. L.
Publicado: (2013)

Statins alone or polypill for primary prevention of cardiovascular diseases
por: Hasani-Ranjbar, Shirin, et al.
Publicado: (2016)

The feasibility of polypill for cardiovascular disease prevention in Asian Population
por: Sukonthasarn, Apichard, et al.
Publicado: (2020)

The Polypill: From Promise to Pragmatism
por: Huffman, Mark D.
Publicado: (2015)

Polypill revisited – Unity in diversity
por: Dan, Gheorghe-Andrei, et al.
Publicado: (2020)

Left Main Equivalent Myocardial Infarction due to Acute Subclavian Artery Thrombosis in a Patient with Prior Coronary Bypass
por: Fonseca, Marta, et al.
Publicado: (2021)

Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction
por: Fernández-Bergés, Daniel, et al.
Publicado: (2020)

Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill
por: Lafeber, M., et al.
Publicado: (2016)

Patient delay and benefit of timely reperfusion in ST-segment elevation myocardial infarction
por: Scholz, Karl Heinrich, et al.
Publicado: (2021)

Cardiovascular care of patients with stroke and high risk of stroke: The need for interdisciplinary action: A consensus report from the European Society of Cardiology Cardiovascular Round Table
por: Doehner, Wolfram, et al.
Publicado: (2019)

Cardiovascular Disease Burden: Evolving Knowledge of Risk Factors in Myocardial Infarction and Stroke through Population-Based Research and Perspectives in Global Prevention
por: Oliveira, Gustavo B. F., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_sj28jciab094vrpeomeggcn7l9